Special Populations: Summary of the Discussion

  • William M. Wardell
  • Giampaolo Velo
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 39)


Special populations need to be investigated to enable valid prescribing information in these patients to be given to the medical practitioner. The risk/benefit ratio was generally considered not to be uniform for all sectors of the population. Efficacy was not generally regarded as being in debate, but it was considered that the toxicological pro-file could vary with sectors of the population.


Data Sheet Legal Document Scientific Thinking Drug Interaction Study Marketing Approval 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • William M. Wardell
    • 1
  • Giampaolo Velo
    • 2
  1. 1.The University of Rochester School of Medicine and DentistryRochesterUSA
  2. 2.University of PaduaVeronaItaly

Personalised recommendations